Author:
Bradley John S.,Peacock Georgina,Krug Steven E.,Bower William A.,Cohn Amanda C.,Meaney-Delman Dana,Pavia Andrew T.,Krug Steven E.,Chung Sarita,Fagbuyi Daniel B.,Fisher Margaret,Needle Scott,Schonfeld David J.,Brady Michael Thomas,Byington Carrie Lynn,Davies H. Dele,Edwards Kathryn M.,Jackson Mary Anne,Maldonado Yvonne Aida,Murray Dennis,Orenstein Walter A.,Rathore Mobeen H.,Sawyer Mark H.,Schutze Gordon E.,Willoughby Rodney E.,Zaoutis Theoklis,
Abstract
Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as “children”) in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology and Child Health
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献